Adherence rates and health care costs in Crohn's disease patients receiving certolizumab pegol with and without home health nurse assistance: results from a retrospective analysis of patient claims and home health nurse data.

Saved in:
Bibliographic Details
Title: Adherence rates and health care costs in Crohn's disease patients receiving certolizumab pegol with and without home health nurse assistance: results from a retrospective analysis of patient claims and home health nurse data.
Authors: Wolf DC; Atlanta Gastroenterology Associates, Atlanta, GA., Jaganathan S; UCB Pharma, Smyrna, GA., Burudpakdee C; IQVIA, Fairfax, VA., Seetasith A; IQVIA, Fairfax, VA., Low R; UCB Pharma, Smyrna, GA., Lee E; UCB Pharma, Atlanta, GA., Gucky J; UCB Pharma, Smyrna, GA., Yassine M; UCB Pharma, Atlanta, GA., Schwartz DA; Inflammatory Bowel Disease Center, Vanderbilt University Medical Center, Vanderbilt University, Nashville, TN, USA.
Source: Patient preference and adherence [Patient Prefer Adherence] 2018 May 21; Vol. 12, pp. 869-878. Date of Electronic Publication: 2018 May 21 (Print Publication: 2018).
Publication Type: Journal Article
Journal Info: Publisher: Dove Press Limited Country of Publication: New Zealand NLM ID: 101475748 Publication Model: eCollection Cited Medium: Print ISSN: 1177-889X (Print) Linking ISSN: 1177889X NLM ISO Abbreviation: Patient Prefer Adherence Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1177-889X
DOI:10.2147/PPA.S148777